Published in J Allergy Clin Immunol Pract on September 29, 2016
STAT3 mutations in the hyper-IgE syndrome. N Engl J Med (2007) 8.99
Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature (2008) 8.17
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A (1997) 7.08
Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature (2007) 7.07
Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science (2011) 6.19
What does Stat3 do? J Clin Invest (2002) 4.83
Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics (1972) 3.75
Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet (1966) 3.27
Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol (2008) 2.50
A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity (2011) 2.15
STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood (2006) 2.12
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy (2013) 2.03
Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol (2007) 1.61
Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol (2010) 1.36
Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant (2000) 1.30
New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol (2011) 1.26
DOCK8 deficiency. Ann N Y Acad Sci (2011) 1.23
Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. J Allergy Clin Immunol (2013) 1.19
Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma (2004) 1.17
Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol (2006) 1.14
STAT3 is required for IL-21-induced secretion of IgE from human naive B cells. Blood (2008) 1.11
Human tyk2 kinase deficiency: another primary immunodeficiency syndrome. Immunity (2006) 1.09
Invasive aspergillosis in primary immunodeficiencies. Med Mycol (2005) 1.07
Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol (2008) 1.03
High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome. J Allergy Clin Immunol (1995) 0.98
Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol (2010) 0.98
STAT3 signaling and the hyper-IgE syndrome. N Engl J Med (2007) 0.98
Pneumatocele complicating hyperimmunoglobulin E syndrome (Job's Syndrome). Ann Thorac Surg (1992) 0.97
Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Med (1998) 0.97
Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol (2011) 0.95
Craniosynostosis in hyper-IgE-syndrome. Eur J Pediatr (1985) 0.94
PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am J Hum Genet (2014) 0.94
Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern. Allergy (2014) 0.92
The development of pulmonary adenocarcinoma in a patient with Job's syndrome, a rare immunodeficiency condition. Tumori (2004) 0.92
Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol (2004) 0.92
Hyper IgE syndrome: review and future directions. Expert Rev Clin Immunol (2005) 0.90
Cutaneous manifestations of hyper-IgE syndrome in infants and children. J Pediatr (2002) 0.87
Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation. Blood (2014) 0.85
Moderate-dose intravenous immunoglobulin treatment of Job's syndrome. Case report. Minerva Med (2000) 0.83
Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome. J Clin Immunol (2013) 0.81
Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome. J Clin Immunol (2015) 0.80
Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children. Pediatr Allergy Immunol (2016) 0.79
Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am (2014) 0.79
Bone density and fractures in autosomal dominant hyper IgE syndrome. J Clin Immunol (2014) 0.78
The development of invasive vulvar cancer in a patient with Job's syndrome, a rare immunodeficient condition. Br J Obstet Gynaecol (1998) 0.77
Commercial air travel after pneumothorax: a review of the literature. Air Med J (2013) 0.77
In-flight spontaneous pneumothorax: congenital cystic adenomatoid malformation of the lung. Respiration (2012) 0.76
Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry. J Allergy Clin Immunol Pract (2017) 0.75